TP53 and plasma cell myeloma: Interestingly, in our hands, while most of the MM cell lines tested were TP53 mutants, MM.1S (TP53WT) cells were sensitive to TriC treatment, suggesting that TriC toxicity in myeloma cells may be independent of TP53 status.